Literature DB >> 25199172

Three-dimensional spectral domain optical coherence tomography in vitreomacular traction.

Sandeep Saxena1, Carsten H Meyer2, Levent Akduman3.   

Abstract

Spectral domain optical coherence tomography (SD-OCT) is a non-invasive tool providing unprecedented imaging and analysis of vitreomacular interface. Two cases of vitreomacular traction were analysed by advanced three-dimensional (3D) SD-OCT imaging. En-face OCT permitted localisation of the exact point of attachment of vitreous to retina. A comprehensive view of the surface topography and anatomical configuration of vitreomacular affection was revealed by 3D imaging with segmentation technique. Macular change analysis programme revealed progression to full-thickness macular hole in the second case. Non-invasive high-resolution SD-OCT imaging has transformed the understanding and management of vitreomacular traction. Its role is further reinforced by the introduction of ocriplasmin for management of vitreomacular adhesions. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 25199172      PMCID: PMC4069793          DOI: 10.1136/bcr-2013-202065

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes.

Authors:  Peter Stalmans; Matthew S Benz; Arnd Gandorfer; Anselm Kampik; Aniz Girach; Stephen Pakola; Julia A Haller
Journal:  N Engl J Med       Date:  2012-08-16       Impact factor: 91.245

2.  Ultrastructural features of tissue removed during idiopathic macular hole surgery.

Authors:  H S Yooh; H L Brooks; A Capone; N L L'Hernault; H E Grossniklaus
Journal:  Am J Ophthalmol       Date:  1996-07       Impact factor: 5.258

3.  The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole.

Authors:  Jay S Duker; Peter K Kaiser; Susanne Binder; Marc D de Smet; Alain Gaudric; Elias Reichel; SriniVas R Sadda; Jerry Sebag; Richard F Spaide; Peter Stalmans
Journal:  Ophthalmology       Date:  2013-09-17       Impact factor: 12.079

4.  Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography.

Authors:  Dominik Odrobina; Zofia Michalewska; Janusz Michalewski; Krzysztof Dzięgielewski; Jerzy Nawrocki
Journal:  Retina       Date:  2011-02       Impact factor: 4.256

5.  Acute panretinal structural and functional abnormalities after intravitreous ocriplasmin injection.

Authors:  Abigail T Fahim; Naheed W Khan; Mark W Johnson
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

6.  Vision loss after intravitreal ocriplasmin: correlation of spectral-domain optical coherence tomography and electroretinography.

Authors:  Michael D Tibbetts; Elias Reichel; Andre J Witkin
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

7.  Ten Years of Severe Vitreomacular Traction Syndrome without Functional Damage Demonstrated by Optical Coherence Tomography.

Authors:  Michele Reibaldi; Teresio Avitabile; Maurizio Giacinto Uva; Francesco Occhipinti; Mario Toro; Marco Zagari; Andrea Russo
Journal:  Case Rep Ophthalmol Med       Date:  2011-09-08
  7 in total
  3 in total

1.  Comparison of the horizontal diameter to a modeled area of traction in eyes with vitreomacular traction: is the diameter close enough to the truth?

Authors:  Christoph Paul; P Krug; H H Müller; J Wachtlin; S Mennel; S Müller; S Schmitz-Valckenberg; T Bertelmann; R G Schumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-28       Impact factor: 3.117

2.  Lamellar macular hole after intravitreal ocriplasmin injection.

Authors:  Ross Bronson Chod; Clifford Goodrich; Sandeep Saxena; Levent Akduman
Journal:  BMJ Case Rep       Date:  2015-01-09

Review 3.  The potential of spectral domain optical coherence tomography imaging based retinal biomarkers.

Authors:  Prateep Phadikar; Sandeep Saxena; Surabhi Ruia; Timothy Y Y Lai; Carsten H Meyer; Dean Eliott
Journal:  Int J Retina Vitreous       Date:  2017-01-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.